# Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma

> **NCT02717455** · PHASE1 · COMPLETED · sponsor: **Pediatric Brain Tumor Consortium** · enrollment: 53 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** LBH589

## Key facts

- **NCT ID:** NCT02717455
- **Lead sponsor:** Pediatric Brain Tumor Consortium
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-28
- **Primary completion:** 2022-02-14
- **Final completion:** 2024-03-31
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2024-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02717455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02717455, "Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02717455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*